Ameriprise’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.46M | Sell |
200,321
-1,200
| -0.6% | -$56.6K | ﹤0.01% | 1853 |
|
|
2025
Q1 | $7.87M | Sell |
201,521
-2,852
| -1% | -$111K | ﹤0.01% | 1943 |
|
|
2024
Q4 | $11.1M | Buy |
204,373
+45,113
| +28% | +$2.44M | ﹤0.01% | 1715 |
|
|
2024
Q3 | $8.03M | Buy |
+159,260
| New | +$8.03M | ﹤0.01% | 1990 |
|
|
2023
Q4 | – | Sell |
-86,862
| Closed | -$4.95M | – | 3949 |
|
|
2023
Q3 | $4.95M | Buy |
+86,862
| New | +$4.95M | ﹤0.01% | 2301 |
|